Results
|
1.
|
|
|
2.
|
|
|
3.
|
Cardiovascular Safety of the β [electronic resource] by
- White, William B
- Chapple, Christopher
- Gratzke, Christian
- Herschorn, Sender
- Robinson, Dudley
- Frankel, Jeffrey
- Ridder, Arwin
- Stoelzel, Matthias
- Paireddy, Asha
- van Maanen, Robert
- Weber, Michael A
Publication details: Journal of clinical pharmacology Aug 2018
In:
Journal of clinical pharmacology vol. 58
Availability: No items available.
|
|
4.
|
Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study). [electronic resource] by
- Herschorn, Sender
- Chapple, Christopher R
- Abrams, Paul
- Arlandis, Salvador
- Mitcheson, David
- Lee, Kyu-Sung
- Ridder, Arwin
- Stoelzel, Matthias
- Paireddy, Asha
- van Maanen, Rob
- Robinson, Dudley
Producer: 20171213
In:
BJU international vol. 120
Availability: No items available.
|
|
5.
|
Patient-reported outcomes from SYNERGY, a randomized, double-blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients. [electronic resource] by
- Robinson, Dudley
- Kelleher, Con
- Staskin, David
- Mueller, Elizabeth R
- Falconer, Christian
- Wang, Jianye
- Ridder, Arwin
- Stoelzel, Matthias
- Paireddy, Asha
- van Maanen, Rob
- Hakimi, Zalmai
- Herschorn, Sender
Producer: 20190926
In:
Neurourology and urodynamics vol. 37
Availability: No items available.
|
|
6.
|
Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE). [electronic resource] by
- Drake, Marcus J
- MacDiarmid, Scott
- Chapple, Christopher R
- Esen, Adil
- Athanasiou, Stavros
- Cambronero Santos, Javier
- Mitcheson, David
- Herschorn, Sender
- Siddiqui, Emad
- Huang, Moses
- Stoelzel, Matthias
Producer: 20180716
In:
International journal of clinical practice vol. 71
Availability: No items available.
|
|
7.
|
Long-term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study. [electronic resource] by
- Mueller, Elizabeth R
- van Maanen, Rob
- Chapple, Christopher
- Abrams, Paul
- Herschorn, Sender
- Robinson, Dudley
- Stoelzel, Matthias
- Yoon, Sang J
- Al-Shukri, Salman
- Rechberger, Tomasz
- Gratzke, Christian
Producer: 20200207
In:
Neurourology and urodynamics vol. 38
Availability: No items available.
|
|
8.
|
A strategy utilizing ambulatory monitoring and home and clinic blood pressure measurements to optimize the safety evaluation of noncardiovascular drugs with potential for hemodynamic effects: a report from the SYNERGY trial. [electronic resource] by
- Weber, Michael A
- Chapple, Christopher R
- Gratzke, Christian
- Herschorn, Sender
- Robinson, Dudley
- Frankel, Jeffrey M
- Ridder, Arwin M
- Stoelzel, Matthias
- Paireddy, Asha
- van Maanen, Robert
- White, William B
Producer: 20180918
In:
Blood pressure monitoring vol. 23
Availability: No items available.
|
|
9.
|
Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II). [electronic resource] by
- Gratzke, Christian
- van Maanen, Rob
- Chapple, Christopher
- Abrams, Paul
- Herschorn, Sender
- Robinson, Dudley
- Ridder, Arwin
- Stoelzel, Matthias
- Paireddy, Asha
- Yoon, Sang Jin
- Al-Shukri, Salman
- Rechberger, Tomasz
- Mueller, Elizabeth R
Producer: 20190425
In:
European urology vol. 74
Availability: No items available.
|